title: Problems identified with phase II stopping rules that employ response and early-progression rates.
authors.forename: James R
authors.initials: JR
authors.lastname: Anderson
authors.forename: Mark D
authors.initials: MD
authors.lastname: Krailo
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008962:Models, Theoretical; D012107:Research Design